These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7871058)

  • 1. Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.
    Goodall EM; Cowen PJ; Franklin M; Silverstone T
    Psychopharmacology (Berl); 1993; 112(4):461-6. PubMed ID: 7871058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that central 5-HT2 receptors do not play an important role in the anorectic activity of D-fenfluramine in the rat.
    Samanin R; Mennini T; Bendotti C; Barone D; Caccia S; Garattini S
    Neuropharmacology; 1989 May; 28(5):465-9. PubMed ID: 2566947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors.
    Neill JC; Cooper SJ
    Psychopharmacology (Berl); 1989; 97(2):213-8. PubMed ID: 2498930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT and carbohydrate suppression: effects of 5-HT antagonists on the action of d-fenfluramine and DOI.
    Lawton CL; Blundell JE
    Pharmacol Biochem Behav; 1993 Oct; 46(2):349-60. PubMed ID: 8265689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the effects of d- and l-fenfluramine and d-amphetamine on energy and macronutrient intake in human subjects.
    Goodall E; Feeney S; McGuirk J; Silverstone T
    Psychopharmacology (Berl); 1992; 106(2):221-7. PubMed ID: 1549650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
    Shukla R; MacKenzie-Taylor D; Rech RH
    Psychopharmacology (Berl); 1990; 100(1):115-8. PubMed ID: 2296618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pindolol on the prolactin response to d-fenfluramine.
    Park SB; Cowen PJ
    Psychopharmacology (Berl); 1995 Apr; 118(4):471-4. PubMed ID: 7568634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of 5-HT receptors in satiation and the effect of d-fenfluramine in the runway test.
    Neill JC; Bendotti C; Samanin R
    Eur J Pharmacol; 1990 Nov; 190(1-2):105-12. PubMed ID: 2127571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion.
    Di Renzo G; Amoroso S; Taglialatela M; Canzoniero L; Basile V; Fatatis A; Annunziato L
    Eur J Pharmacol; 1989 Mar; 162(2):371-3. PubMed ID: 2524399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task.
    Carli M; Samanin R
    Psychopharmacology (Berl); 1992; 106(2):228-34. PubMed ID: 1532259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal and temperature responses to flesinoxan in normal volunteers: an antagonist study.
    Pitchot W; Wauthy J; Legros JJ; Ansseau M
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):151-5. PubMed ID: 15013031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of the anorectic actions of 5-HTP and fenfluramine.
    Fletcher PJ; Burton MJ
    Psychopharmacology (Berl); 1986; 89(2):216-20. PubMed ID: 3088639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects.
    Coccaro EF; Kavoussi RJ; Oakes M; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Jul; 126(1):24-30. PubMed ID: 8853213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
    van Laar M; Volkerts E; Verbaten M
    Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system.
    Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Sgrò M; Franchi F; Luisi M
    Horm Res; 1989; 31(3):133-7. PubMed ID: 2501208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels.
    Belohlávková S; Simák J; Kokesová A; Hnilicková O; Hampl V
    J Appl Physiol (1985); 2001 Aug; 91(2):755-61. PubMed ID: 11457791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 5-HT receptors in the effect of d-fenfluramine on feeding patterns in the rat.
    Grignaschi G; Samanin R
    Eur J Pharmacol; 1992 Mar; 212(2-3):287-9. PubMed ID: 1601071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects.
    Seibyl JP; Krystal JH; Price LH; Woods SW; D'Amico C; Heninger GR; Charney DS
    Psychiatry Res; 1991 Sep; 38(3):227-36. PubMed ID: 1754635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA; Sherman BM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.